Biolinq attracts $100m Series B
Biolinq Incorporated, a medical device company, has secured $100 million in Series B financing.
Biolinq Incorporated, a medical device company, has secured $100 million in Series B financing.
Copyright PEI Media
Not for publication, email or dissemination